SecBot SecBot
SECBOTREPLAY Home › Report › ORKA

ORKA · Oruka Therapeutics priced an upsized underwritten public offering of…

Oruka Therapeutics, Inc. · PRESS-RELEASE filed Apr 28, 2026 at 19:42 ET

At the news

BEARISHIMPACT 6/10

PRESS-RELEASE filed Apr 28, 2026 at 19:42 ET

Oruka Therapeutics priced an upsized underwritten public offering of 9.66 million shares at $72.50 per share, raising approximately $700.4 million in gross proceeds. The substantial dilution (~18% of current shares outstanding) is likely to pressure the stock near term, though the capital bolsters its clinical-stage pipeline.

  • Offering of 9,660,000 shares at $72.50 per share
  • Gross proceeds of ~$700.4 million
  • Underwriters have 30-day option for additional 1,449,000 shares
  • Expected closing on April 30, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access